JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.23% |
| 2 | Technology | 15.68% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MMAT
4726
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $360K | ﹤0.01% |
+481
| New | +$268K |
2021 Q2
0 quarters
|
|
|
HUYA
4727
Huya Inc
HUYA
$523M
| $358K | ﹤0.01% |
20,280
-405
| -2% | -$6.79K |
2018 Q2
12 quarters
|
|
4728
PUT
Kinder Morgan
KMI
$68B
| $357K | ﹤0.01% |
+19,600
| New | +$349K |
2021 Q2
0 quarters
|
|
|
RRD
4729
DELISTED
RR Donnelley & Sons Co.
RRD
| $357K | ﹤0.01% |
56,724
+56,717
| +810,243% | +$309K |
2016 Q4
18 quarters
|
|
|
BCAB
4730
DELISTED
BIOATLA INC
BCAB
| $356K | ﹤0.01% |
168
-1,434
| -90% | -$3.24M |
2020 Q4
2 quarters
|
|
4731
Limoneira
LMNR
$216M
| $355K | ﹤0.01% |
20,232
-27,014
| -57% | -$495K |
2017 Q4
14 quarters
|
|
4732
CALL
XPeng
XPEV
$9.02B
| $355K | ﹤0.01% |
8,000
-172,700
| -96% | -$5.89M |
2020 Q3
3 quarters
|
|
|
4733
PUT
XPeng
XPEV
$9.02B
| $355K | ﹤0.01% |
+8,000
| New | +$273K |
2021 Q2
0 quarters
|
|
|
SLCT
4734
DELISTED
Select Bancorp, Inc.
SLCT
| $355K | ﹤0.01% |
21,965
-531,505
| -96% | -$7.34M |
2018 Q2
12 quarters
|
|
|
GAMCU
4735
DELISTED
Golden Arrow Merger Corp. Unit
GAMCU
| $354K | ﹤0.01% |
35,572
-173,423
| -83% | -$1.72M |
2021 Q1
1 quarter
|
|
4736
CNB Financial Corp
CCNE
$998M
| $353K | ﹤0.01% |
15,461
-24,425
| -61% | -$596K |
2017 Q4
14 quarters
|
|
|
GRTX
4737
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $353K | ﹤0.01% |
35,973
+12,319
| +52% | +$100K |
2019 Q4
6 quarters
|
|
|
AUD
4738
DELISTED
Audacy, Inc.
AUD
| $353K | ﹤0.01% |
81,964
-276,867
| -77% | -$1.27M |
2013 Q2
32 quarters
|
|
|
CAJ
4739
DELISTED
Canon, Inc.
CAJ
| $353K | ﹤0.01% |
15,635
+3,208
| +26% | +$75.6K |
2013 Q2
32 quarters
|
|
4740
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.29B
| $352K | ﹤0.01% |
11,981
-36
| -0.3% | -$1.07K |
2013 Q2
32 quarters
|
|
4741
TherapeuticsMD
TXMD
$23.5M
| $352K | ﹤0.01% |
5,930
-7,310
| -55% | -$443K |
2015 Q1
25 quarters
|
|
|
VXRT
4742
DELISTED
Vaxart
VXRT
| $350K | ﹤0.01% |
46,672
+26,348
| +130% | +$184K |
2020 Q2
4 quarters
|
|
4743
Centrus Energy
LEU
$2.85B
| $347K | ﹤0.01% |
+13,672
| New | +$327K |
2021 Q2
0 quarters
|
|
4744
Pixelworks
PXLW
$41.6M
| $347K | ﹤0.01% |
8,490
-1,062
| -11% | -$41.7K |
2020 Q2
4 quarters
|
|
|
MCBC
4745
DELISTED
Macatawa Bank Corp
MCBC
| $347K | ﹤0.01% |
39,715
-32,990
| -45% | -$315K |
2015 Q4
22 quarters
|
|
|
VRAY
4746
DELISTED
ViewRay, Inc.
VRAY
| $347K | ﹤0.01% |
52,659
-511,021
| -91% | -$2.72M |
2016 Q4
18 quarters
|
|
4747
Clover Health Investments
CLOV
$2.25B
| $346K | ﹤0.01% |
+25,983
| New | +$255K |
2021 Q2
0 quarters
|
|
4748
CorMedix
CRMD
$578M
| $346K | ﹤0.01% |
50,443
-7,903
| -14% | -$62.9K |
2019 Q2
8 quarters
|
|
4749
Ardmore Shipping
ASC
$786M
| $345K | ﹤0.01% |
81,722
-21,576
| -21% | -$92.2K |
2017 Q3
15 quarters
|
|
4750
ARK Space & Defense Innovation ETF
ARKX
$758M
| $344K | ﹤0.01% |
+16,372
| New | +$336K |
2021 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $31.1B of net new capital in Q2 2021, opening 693 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 693 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.